Previous Close | 72.67 |
1-Year Change | 198.19% |
6-Months Change | 200.79% |
3-Months Change | -8.02% |
Moving Avg (50d) | 72.07 |
Moving Avg (200d) | 54.054 |
ESG Rating | - |
Exchange | NASDAQ |
Market Cap. | 13.0B |
Beta (3-Years) | 1.12 |
Revenue Growth (ttm) | 22.13% |
Net Profit Margin (ttm) | -252.01% |
Return On Assets (ttm) | -42.1% |
EPS (ttm) | -5.55 |
PE Ratio (ttm) | -13.09 |
Dividend Yield | % |
Disclaimer - Please note that the use of AI to analyse contents may occasionally generate incorrect information.
Our cutting-edge algorithms employ macroeconomic data, fundamental and technical analysis indicators to accurately predict the optimal position for short-term trading
By harnessing these signals, we power our asset allocation tools, backtesting tool and portfolio management process, ensuring maximum returns for your investments.
Sector: | Health Care |
Industry: | Biotechnology |
Country: | United States |